GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
4CQX | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Human Receptor Analogue 6'SLN | |
4CQY | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Avian Receptor Analogue LSTa | |
4CQW | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN | |
4CQR | Q6DQ34 | H5 (VN1194) Ser227Asn/Gln196Arg Mutant Haemagglutinin in Complex with Human Receptor Analogue 6'SLN | |
4CQQ | Q6DQ34 | H5 (VN1194) Ser227Asn/Gln196Arg Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN | |
4BGX | Q6DQ34 | H5 (VN1194) Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue 6'-SLN | |
4BGY | Q6DQ34 | H5 (VN1194) Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN | HEMAGGLUTININ |
4CQU | Q6DQ34 | H5 (VN1194) Asn186Lys Mutant Haemagglutinin in Complex with Human Receptor Analogue 6'SLN | |
4CQS | Q6DQ34 | H5 (VN1194) Asn186Lys Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN | |
5AJM | Q6DQ34 | H5 (VN1194) Asn186Lys Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN | |
3UQY | P0ACD8 | H2-reduced structure of E. coli hydrogenase-1 | |
3UQY | P69739 | H2-reduced structure of E. coli hydrogenase-1 | |
8TP9 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP9 | 8TP9 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP7 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
8TP7 | 8TP7 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
8TP6 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
8TP6 | 8TP6 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
8TP4 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04 | |
8TP4 | 8TP4 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04 | |
8TP2 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting 1-1-1F05 | |
8TP2 | 8TP2 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting 1-1-1F05 | |
4B7J | F8UU09 | H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | NEURAMINIDASE |
4B7M | F8UU09 | H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | |
4B7N | F8UU09 | H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | |
4B7Q | C7FH46 | H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | NEURAMINIDASE |
4B7R | C7FH46 | H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis | NEURAMINIDASE |
6ZBP | P0DTC2 | H11-H4 complex with SARS-CoV-2 | |
6ZBP | 6ZBP | H11-H4 complex with SARS-CoV-2 | |
6ZHD | P10104 | H11-H4 bound to Spike | Spike glycoprotein,Fibritin, Nanobody H11-H4 |
6ZHD | P0DTC2 | H11-H4 bound to Spike | Spike glycoprotein,Fibritin, Nanobody H11-H4 |
6ZHD | 6ZHD | H11-H4 bound to Spike | Spike glycoprotein,Fibritin, Nanobody H11-H4 |
6YZ7 | P0DTC2 | H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex | |
6YZ7 | 6YZ7 | H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex | |
6Z2M | P0DTC2 | H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex | |
6Z2M | 6Z2M | H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex | |
6YZ5 | P0DTC2 | H11-D4 complex with SARS-CoV-2 RBD | |
6YZ5 | 6YZ5 | H11-D4 complex with SARS-CoV-2 RBD | |
8TPA | Q6WG00 | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TPA | 8TPA | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP3 | Q6WG00 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1F05 | |
8TP3 | 8TP3 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1F05 | |
8TP5 | Q6WG00 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
8TP5 | 8TP5 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
7UMM | A7Y8I1 | H1 Solomon Islands 2006 hemagglutinin in complex with Ab109 | |
7UMM | 7UMM | H1 Solomon Islands 2006 hemagglutinin in complex with Ab109 | |
7ACX | Q8KHI4 | H/L (SLPH/SLPL) complex from C. difficile (R7404 strain) | |
7ACX | Q9AEM2 | H/L (SLPH/SLPL) complex from C. difficile (R7404 strain) | |
2J5Z | O75636 | H-ficolin complexed to galactose | |
2J60 | O75636 | H-ficolin complexed to D-fucose |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024